Parallel Advisors’s Cellebrite CLBT Stock Holding History

Parallel Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.5K	Buy	2,089 +89	+4%	+$1.18K	﹤0.01%	2426
2026 Q1	$27.6K	Hold	2,000	–	–	﹤0.01%	2324
2025 Q4	$36.1K	Hold	2,000	–	–	﹤0.01%	2022
2025 Q3	$37.1K	Hold	2,000	–	–	﹤0.01%	1941
2025 Q2	$32K	Hold	2,000	–	–	﹤0.01%	1959
2025 Q1	$38.9K	Hold	2,000	–	–	﹤0.01%	1780
2024 Q4	$44.1K	Hold	2,000	–	–	﹤0.01%	1704
2024 Q3	$33.7K	Hold	2,000	–	–	﹤0.01%	1824
2024 Q2	$23.9K	Hold	2,000	–	–	﹤0.01%	1877
2024 Q1	$22.2K	Sell	2,000 -1,500	-43%	-$15.3K	﹤0.01%	1922
2023 Q4	$30.3K	Buy	3,500 +1,500	+75%	+$11.7K	﹤0.01%	1686
2023 Q3	$15.3K	Hold	2,000	–	–	﹤0.01%	1984
2023 Q2	$14.4K	Hold	2,000	–	–	﹤0.01%	2015
2023 Q1	$12.2K	Hold	2,000	–	–	﹤0.01%	2049
2022 Q4	$8.72K	Hold	2,000	–	–	﹤0.01%	2086
2022 Q3	$8K	Hold	2,000	–	–	﹤0.01%	2071
2022 Q2	$10K	Hold	2,000	–	–	﹤0.01%	1967
2022 Q1	$13K	Hold	2,000	–	–	﹤0.01%	1886
2021 Q4	$16K	Hold	2,000	–	–	﹤0.01%	1886
2021 Q3	$19K	Buy	+2,000	New	+$20.9K	﹤0.01%	1751

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Parallel Advisors's CLBT Position: Q2 2026 in Review

Parallel Advisors increased its Cellebrite (CLBT) stake by 4.5% in Q2 2026, buying an estimated $1.18K and bringing the position to 2,089 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2426.

Parallel Advisors first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $44.1K in Q4 2024. 133 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Parallel Advisors held 2,089 shares of Cellebrite worth $30.5K as of Q2 2026.
Parallel Advisors bought 89 Cellebrite shares in Q2 2026, an estimated $1.18K.
Cellebrite made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2426 holding.
Parallel Advisors first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
Parallel Advisors's Cellebrite position peaked at $44.1K in Q4 2024.
133 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.